Synchronous Breast Implant–associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications
SUMMARY:. A 59-year-old woman with a history of cosmetic implants developed ipsilateral synchronous breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) and invasive ductal carcinoma in the left breast. Each tumor was subjected to next-generation sequencing, and separate analyses reve...
Main Authors: | Rita A. Mukhtar, MD, Michael Holland, MD, David A. Sieber, MD, Kwun Wah Wen, MD, PhD, Hope S. Rugo, MD, Marshall E. Kadin, MD, Gregory R. Bean, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2019-04-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000002188 |
Similar Items
-
Abstract: Validation of a CD30 ELISA for the Rapid Detection of Breast Implant Associated Anaplastic Large Cell Lymphoma
by: Summer E. Hanson, MD, PhD, et al.
Published: (2017-09-01) -
Breast implant-associated anaplastic large cell lymphoma with contralateral invasive lobular carcinoma
by: Lisa Johnson, MD, et al.
Published: (2020-12-01) -
Educational Case: ALK-Negative Anaplastic Large Cell Lymphoma
by: Akira Satou MD, PhD, et al.
Published: (2020-01-01) -
Synchronous breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and silicone induced granuloma of breast implant capsule (SIGBIC): What to learn
by: Eduardo de Faria Castro Fleury, MD, PhD, and Post-Doctorate
Published: (2020-10-01) -
Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma
by: Grace L. Smith, MD, PhD, MPH, et al.
Published: (2017-07-01)